TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
CRL

Charles River Laboratories

Healthcare · Diagnostics & Research

292.80$ -0.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

Charles River Laboratories (CRL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 180 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow CRL
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
205 221 130 194 252 159 172 205 214 148 41 180 582
79 81 85 86 88 102 120 120 85 78 67 67 298
23 20 17 17 19 17 13 17 23 18 22 20 83
37 – – – – – – – – – – – –
2.3 38 -48 -11 71 -42 1.3 11 -5.1 6.8 -106 3.0 -101
66 78 79 39 39 76 59 35 36 89 56 31 212
-80 -238 -86 -62 -21 -76 -45 -37 -34 -74 -408 28 -487
3.9 5.9 – – – – – – – – – – –
0.0 -0.1 -9.4 -8.9 -101 -0.1 -353 -7.4 -0.1 -0.1 -208 -116 -324
-163 – – – -94 -72 267 -191 -146 -51 557 -37 322
-163 124 18 -286 -208 -76 -105 -227 -153 -52 348 -165 -21
-43 119 54 -158 31 -6.1 26 -47 24 6.8 -18 42 56
140 143 51 154 213 84 112 169 178 59 -15 149 371

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?